Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays
Yohei Hisada(University of North Carolina at Chapel Hill), Nigel Mackman(University of North Carolina at Chapel Hill), Nigel S. Key(University of North Carolina at Chapel Hill), Håkan Wallén(Karolinska Institutet), Fariborz Mobarrez(Karolinska Institutet), Raj S. Kasthuri(University of North Carolina at Chapel Hill), Peter M. Voorhees(Levine Cancer Institute), Coleen A. McNamara(Carter Center), Wyeth Alexander(University of North Carolina at Chapel Hill), Marco Witkowski(Cleveland Clinic), Ursula Rauch(Charité - Universitätsmedizin Berlin), Angela M. Taylor(National Hospital for Neurology and Neurosurgery)
Cited by 82
Related Papers
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
|Journal of Clinical Oncology|2019|1.5k
Gut Microbiota and Cardiovascular Disease
|Circulation Research|2020|1k
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
|New England Journal of Medicine|2022|457
Venous thrombosis
|Nature Reviews Disease Primers|2015|378